You are here: Industry Insights > pneumonia

News List

EC grants approval to Merck’s pneumonia vaccine for use in adults Pharmaceutical-Technology
December 17, 2021
The European Commission (EC) has granted approval to Merck’s (MSD) pneumococcal 15-valent conjugate vaccine, Vaxneuvance, for active immunisation to prevent invasive disease and pneumonia in adults aged 18 years and above.
Antibiotic-Resistant Pneumonia Is Killing Children in Bangladesh — Could It Spread? drugs
July 16, 2021
Antibiotic-resistant bacteria is causing deadly pneumonia infections among large numbers of children in the South Asian nation of Bangladesh, a rising threat that could one day reach American shores, experts warn.
Less Than 1 Percent of COVID-19 Patients Experience Reinfection drugs
June 29, 2021
Reinfection following COVID-19 is possible, but rare, according to a study recently published in Clinical Infectious Diseases.
RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19 prnasia
June 22, 2021
RedHill Biopharma Ltd. announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640)[1] in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021.
Pfizer’s JAK inhibitor Xeljanz shows benefit in COVID-19 pneumonia pharmatimes
June 21, 2021
Pfizer’s JAK inhibitor Xeljanz reduced the risk of severe outcomes in hospitalised adult patients with COVID-19 pneumonia who were not on ventilation, according to new study data.
Duke University researchers identify new coronavirus threat to humans expresspharma
May 21, 2021
Researchers have discovered a new coronavirus, found in a child with pneumonia in Malaysia in 2018, that appears to have jumped from dog to human.
RedHill Announces Opaganib as Compassionate Use Treatment for COVID-19 americanpharmaceuticalreview
March 25, 2021
RedHill Biopharma has acted on a request to provide opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffering from COVID-19 pneumonia.
Optimising a panel for microbiologic diagnosis of pneumonia europeanpharmaceuticalreview
January 20, 2021
Researchers studying the microbiologic diagnosis of pneumonia have identified ways to optimise a pneumonia panel.
Gufic Biosciences gets Tigecycline patent by Eurasian Patent Office expresspharma
November 30, 2020
Tigecycline is a tetracycline antibiotic medication used for a number of bacterial infections.
XENLETA Demonstrates High Efficacy in Community-Acquired Bacterial Pneumonia americanpharmaceuticalreview
October 16, 2020
Nabriva Therapeutics announced in a post-hoc analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 trials by age, XENLETA™ (lefamulin) demonstrated consistently high efficacy and similar safety and tolerability profiles across all ...

Previous page 1 2 3 4 5 Next page